India · Delayed Price · Currency is INR Banka BioLoo Statistics
Total Valuation
Banka BioLoo has a market cap or net worth of INR 985.20 million. The enterprise value is 1.31 billion.
| Market Cap | 985.20M |
| Enterprise Value | 1.31B |
Important Dates
The last earnings date was Tuesday, May 26, 2026.
| Earnings Date | May 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Banka BioLoo has 10.87 million shares outstanding. The number of shares has increased by 13.01% in one year.
| Current Share Class | 10.87M |
| Shares Outstanding | 10.87M |
| Shares Change (YoY) | +13.01% |
| Shares Change (QoQ) | +55.50% |
| Owned by Insiders (%) | 52.43% |
| Owned by Institutions (%) | n/a |
| Float | 5.17M |
Valuation Ratios
The trailing PE ratio is 283.13.
| PE Ratio | 283.13 |
| Forward PE | n/a |
| PS Ratio | 1.73 |
| PB Ratio | 2.31 |
| P/TBV Ratio | 2.50 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 93.60 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 334.10 |
| EV / Sales | 2.30 |
| EV / EBITDA | 25.13 |
| EV / EBIT | 54.16 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.58, with a Debt / Equity ratio of 0.96.
| Current Ratio | 1.58 |
| Quick Ratio | 0.94 |
| Debt / Equity | 0.96 |
| Debt / EBITDA | 7.85 |
| Debt / FCF | -8.25 |
| Interest Coverage | 0.65 |
Financial Efficiency
Return on equity (ROE) is 1.06% and return on invested capital (ROIC) is 3.59%.
| Return on Equity (ROE) | 1.06% |
| Return on Assets (ROA) | 1.64% |
| Return on Invested Capital (ROIC) | 3.59% |
| Return on Capital Employed (ROCE) | 4.13% |
| Weighted Average Cost of Capital (WACC) | 9.35% |
| Revenue Per Employee | 514,810 |
| Profits Per Employee | 3,545 |
| Employee Count | 1,109 |
| Asset Turnover | 0.62 |
| Inventory Turnover | 7.01 |
Taxes
| Income Tax | -6.58M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +22.91% in the last 52 weeks. The beta is 1.09, so Banka BioLoo's price volatility has been similar to the market average.
| Beta (5Y) | 1.09 |
| 52-Week Price Change | +22.91% |
| 50-Day Moving Average | 78.40 |
| 200-Day Moving Average | 73.86 |
| Relative Strength Index (RSI) | 62.31 |
| Average Volume (20 Days) | 7,343 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Banka BioLoo had revenue of INR 570.92 million and earned 3.93 million in profits. Earnings per share was 0.32.
| Revenue | 570.92M |
| Gross Profit | 152.59M |
| Operating Income | 23.96M |
| Pretax Income | -2.65M |
| Net Income | 3.93M |
| EBITDA | 51.97M |
| EBIT | 23.96M |
| Earnings Per Share (EPS) | 0.32 |
Balance Sheet
The company has 110.08 million in cash and 408.03 million in debt, with a net cash position of -297.95 million or -27.40 per share.
| Cash & Cash Equivalents | 110.08M |
| Total Debt | 408.03M |
| Net Cash | -297.95M |
| Net Cash Per Share | -27.40 |
| Equity (Book Value) | 425.75M |
| Book Value Per Share | 23.93 |
| Working Capital | 248.05M |
Cash Flow
In the last 12 months, operating cash flow was 10.53 million and capital expenditures -59.97 million, giving a free cash flow of -49.45 million.
| Operating Cash Flow | 10.53M |
| Capital Expenditures | -59.97M |
| Depreciation & Amortization | 28.01M |
| Net Borrowing | 46.27M |
| Free Cash Flow | -49.45M |
| FCF Per Share | -4.55 |
Margins
Gross margin is 26.73%, with operating and profit margins of 4.20% and 0.69%.
| Gross Margin | 26.73% |
| Operating Margin | 4.20% |
| Pretax Margin | -0.46% |
| Profit Margin | 0.69% |
| EBITDA Margin | 9.10% |
| EBIT Margin | 4.20% |
| FCF Margin | n/a |
Dividends & Yields
Banka BioLoo does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.01% |
| Shareholder Yield | -13.01% |
| Earnings Yield | 0.40% |
| FCF Yield | -5.02% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 8, 2020. It was a forward split with a ratio of 2.5.
| Last Split Date | Sep 8, 2020 |
| Split Type | Forward |
| Split Ratio | 2.5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |